Cialis Lifecycle Management: Lilly's BPH Dilemma
sales of the CIALIS brand product totaled more than $206 million (U.S.), and worldwide sales of CIALIS brand product were in excess of $550 million (U.S.).
What Are the Key Risks and Uncertainties?
Approximately 50 percent of men between 40-70 years old have ED. BPH is a condition where the prostate enlarges, which can cause urinary symptoms. Needing to push or strain during urination Nocturia, or needing to go excessively at night ED and BPH are conditions that may occur in the same patient. Several studies have shown that many men with ED also experience the symptoms of BPH. Cialis is currently approved for ED in more than 100 countries throughout the world.
Price Competition and Consolidation
In the United States, Cialis provides men with ED two different dosing options Cialis for once daily use (2.5 mg and 5 mg) and Cialis for use as needed (5 mg, 10 mg and 20 mg). Cialis is not to be taken more than one time each day. Cialis for once daily use is approved to treat ED, the signs and symptoms of BPH, and ED and the signs and symptoms of BPH in men who have both conditions (ED+BPH). Cialis 5 mg for once daily use is the recommended dose to treat BPH and ED+BPH. Cialis for once daily use can help men with ED be ready anytime between doses*, so they do not have to plan sexual activity around taking a pill.
Generic Alternatives
It can also treat the signs and symptoms of BPH. Cialis for once daily use is the only medication approved to treat both ED and the signs and symptoms of BPH. Cialis for use as needed is approved to treat erectile dysfunction (ED). Cialis for use as needed should be taken before sexual activity. It may go to work quickly (in as little as 30 minutes in some men) and can work up to 36 hours.*+ The most common side effects with Cialis are headache, indigestion, back pain, muscle aches, flushing and stuffy or runny nose. Complainant’s alleged sales of CIALIS brand product exceed $1 billion (U.S.). Complainant alleges that it has an Internet presence, primarily through the website accessed by the domain name
- Cialis Lilly differentiates itself with a well-established safety record over more than a decade.
- The company provides healthcare professionals with comprehensive prescribing information.
- Lilly emphasizes personalized care, tailoring dosage to patient response.
- Online telehealth services now often provide prescriptions for Cialis Lilly with proper evaluation.
- Cialis Lilly should be used cautiously with other ED therapies or herbal supplements.
- It does not cause dependency but requires proper medical oversight.
- Patient support programs include counseling and adherence guidance.
- Cialis Lilly’s impact is enhanced by addressing psychological factors affecting ED.
- It plays a role in managing the sexual health of men with chronic conditions.
- Regulatory authorities monitor adverse event reports to ensure ongoing safety.
The
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Cialis Super Active | 20mg | 90 + 10 Pills | 314.14€ 299.18€ | |
| Cialis Generic | 40mg | 360 + 10 Pills | 477.87€ 455.11€ | |
| Cialis Generic | 2.5mg | 360 + 10 Pills | 260.03€ 247.65€ | |
| Cialis Generic | 20mg | 180 + 10 Pills | 254.09€ 241.99€ | |
| Cialis Professional | 20mg | 10 Pills | 48.29€ 45.99€ | |
| Cialis Generic | 5mg | 90 + 6 Pills | 115.91€ 110.39€ | |
| Cialis Generic | 60mg | 10 Pills | 41.22€ 39.26€ | |
| Cialis Original | 20mg | 14 + 2 Pills | 95.75€ 91.19€ | |
| Cialis Professional | 40mg | 60 + 2 Pills | 262.32€ 249.83€ | |
| Cialis Generic | 60mg | 20 Pills | 65.61€ 62.49€ | |
| Cialis Original | 20mg | 64 + 4 Pills | 274.18€ 261.12€ | |
| Cialis Generic | 10mg | 60 + 6 Pills | 105.81€ 100.77€ | |
| Cialis Professional | 40mg | 180 + 4 Pills | 618.23€ 588.79€ | |
| Cialis Black | 80mg | 30 + 2 Pills | 89.11€ 84.87€ | |
| Cialis Black | 80mg | 270 + 10 Pills | 502.88€ 478.93€ | |
| Cialis Generic | 20mg | 20 Pills | 54.72€ 52.11€ | |
| Cialis Original | 20mg | 48 + 4 Pills | 224.69€ 213.99€ |
Complainant alleges that it has used this domain name to identify a website since at least June�2001.
Summary of Market and Financial Outlook
For further discussion of these and other risks and uncertainties, see Lilly's filings with the United States Securities and Exchange Commission. Lilly undertakes no duty to update forward-looking statements. Impotence and cialis 5 mg tablet its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Relationship between lower urinary tract symptoms and erectile dysfunction: results from the Boston Area community Health Survey.
Drug Interactions:
Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia. The Complainant is Lilly ICOS LLC, a limited liability company organized under the laws of the State of Delaware, United States of America, represented by Baker & Daniels, United States of America. The Respondent is P F, Box 15, FT Laud, FL 33033, United States of America, of United States of America. The disputed domain name
Does Cialis make you last longer?
On March�9,�2007, the Center transmitted by email to eNom a request for registrar verification in connection with the domain name at issue. On March�15,�2007, eNom transmitted by email to the Center its verification response confirming that the Respondent is listed as the registrant and providing the contact details. The Center verified that the Complaint satisfied the formal requirements of the Uniform Domain Name Dispute Resolution Policy (the “Policy”), the Rules for Uniform Domain Name Dispute Resolution Policy (the “Rules”), and the WIPO Supplemental Rules for Uniform Domain Name Dispute Resolution Policy (the “Supplemental Rules”). In accordance with the Rules, paragraphs 2(a) and 4(a), the Center formally notified the Respondent of the Complaint, and the proceedings commenced on March�26,�2007. In accordance with the Rules, paragraph 5(a), the due date for Response was April�15,�2007. Respondent registered the Domain Name on January�2,�2006.
- Patient adherence to Cialis Lilly treatment plans correlates strongly with improved life quality.
- Prescription guidelines emphasize starting at low doses to assess tolerance.
- Cialis Lilly’s dual indication makes it unique among PDE5 inhibitors.
- Healthcare providers assess cardiovascular status before recommending Cialis.
- Individualized therapy may include combination with lifestyle changes and counseling.
- Medical advances continue to explore new applications of tadalafil beyond ED and BPH.
- Cialis Lilly tablets are easy to swallow and designed for convenient daily use.
- The brand supports clinical research through sponsorships and grants.
- Cialis Lilly has contributed to destigmatizing erectile dysfunction in public health.
- Patient testimonials often highlight restored intimacy and confidence following treatment.
Complainant submits that the CIALIS mark is an invented word that has a high degree of individuality, inherent distinctiveness and no common colloquial use.
| Parameter | Details | Notes |
|---|---|---|
| Absorption | Rapid, within 30-60 minutes | Food may delay absorption |
| Duration of Action | Up to 36 hours | Variable depending on individual |
| Metabolism | Primarily via CYP3A4 enzyme | Liver metabolism |
| Elimination Half-life | Approximately 17.5 hours | Long half-life allows flexible dosing |
Complainant further alleges that the Domain Name is confusingly similar to the CIALIS mark.
- Cialis Lilly is part of a broader portfolio by Eli Lilly that addresses several medical conditions.
- Its patent expiration has led to more affordable generics entering the market.
- Lilly maintains stringent manufacturing standards for Cialis products.
- Patients should disclose all medications and health conditions before starting Cialis.
- The brand conducts patient assistance programs for affordability in some regions.
- Cialis Lilly tablets are scored for easy splitting if needed to adjust dose.
- Erectile dysfunction can also be influenced by psychological factors; Cialis addresses physical causes.
- Cialis Lilly must be taken cautiously in patients with heart conditions.
- Regular medical follow-up is recommended to monitor effectiveness and safety.
- Cialis Lilly promotes balanced lifestyle as part of overall ED management.
Complainant argues that the addition of a descriptive term to the trademark CIALIS does not lessen the confusing similarity. Further, Complainant presents prior Panel decisions that found that the incorporation of a distinctive mark in its entirety into a domain name creates sufficient similarity between a mark and a domain name to render the domain name confusingly similar.
About the Company
The Respondent did not submit any response. Accordingly, the Center notified the Respondent’s default on April�18,�2007. The Center appointed Andrew Mansfield as the sole panelist in this matter on April�30,�2007. The Panel finds that it was properly constituted. The Panel has submitted the Statement of Acceptance and Declaration of Impartiality and Independence, as required by the Center to ensure compliance with the Rules, paragraph 7.
Cialis Cost:
Complainant owns the United States Federal trademark CIALIS. The CIALIS mark was registered on the principal register (Registration No. 2,724,589) on June�10,�2003, giving Complainant a constructive use date of June�17,�1999. In addition, Complainant has approximately 130 trademark registrations and applications in approximately 117 nations around the world. The trademark CIALIS designates a pharmaceutical preparation intended for the treatment of erectile dysfunction.
More FAQ
Complainant alleges that Complainant’s decision to use the CIALIS trademark to identify its pharmaceutical product was made public in July�2001. Complainant alleges that Complainant began selling pharmaceutical products identified by the CIALIS mark on January�22,�2003, in the European Union, followed soon thereafter by sales in Australia and New Zealand. Complainant began sales in the United States in November�2003. Complaint states that the product introduction received significant press coverage worldwide. Complainant alleges that in 2004, Complainant spent approximately $39 million (U.S.) to market and sell its CIALIS brand product worldwide, U.S. Complainant urges this Panel to find in accord with those prior Panels.
Lilly ICOS' Cialis (tadalafil) Makes Impressive Strides in First Six Months on the U.S. ED Treatment Market
Back pain and muscle aches usually go away within two days. Not studied for multiple attempts per dose.+ In clinical trials, Cialis for use as needed started to work in 30 minutes for some men who took 20 mg of Cialis for use as needed. When taken as needed, Cialis was shown to improve, up to 36 hours after dosing, the ability of men with ED to have a single successful intercourse attempt. Before taking Cialis, tell your healthcare provider about all your medical problems, particularly if you have or ever had: heart problems such as chest pain (angina), heart failure, irregular heartbeats, or have had a heart attack high or low blood pressure or have high blood pressure that is not controlled retinitis pigmentosa, a rare genetic (runs in families) eye disease severe vision loss, including a condition called NAION a deformed penis shape or Peyronie's disease an erection that lasted more than 4 hours blood cell problems such as sickle cell anemia, multiple myeloma, or leukemia Tell your healthcare provider about all the medicines you take especially if you take: medicines called "nitrates" which are often prescribed for chest pain alpha-blockers often prescribed for prostate problems medicines for HIV or some types of oral antifungal medications some types of antibiotics such as clarithromycin, telithromycin, erythromycin (several brand names exist, please contact your healthcare provider to determine if you are taking this medicine) other medicines or treatments for erectile dysfunction (ED) Cialis is also marketed as Adcirca for the treatment of pulmonary arterial hypertension. Do not take sildenafil citrate (Revatio®)* with Cialis.
Prescription Trends and Adoption
You are encouraged to report negative side effects of prescription drugs to the FDA. protect a man or his partner from sexually transmitted diseases, including HIV serve as a male form of birth control For additional information, talk to your doctor and see full Patient Information at and Prescribing Information at or visit for more information. * The brand listed is a trademark of its respective owner and is not a trademark of Eli Lilly and Company. The maker of this brand is not affiliated with and does not endorse Eli Lilly and Company or its products. About Eli Lilly and Company Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations.
What Are the Side Effects of Cialis and Tadalafil?
Headquartered in Indianapolis, Ind., Lilly provides answers through medicines and information for some of the world's most urgent medical needs. This press release contains forward-looking statements about the potential of Cialis for the treatment of signs and symptoms of benign prostatic hyperplasia (BPH) and reflects Lilly's current beliefs. However, as with any pharmaceutical product, there are substantial risks and uncertainties in the process of development, commercialization, and regulatory review. There is no guarantee that Cialis will receive additional regulatory approvals. There is also no guarantee that Cialis will continue to be commercially successful. Complainant alleges that Respondent has no rights or legitimate interests in the Domain Name. Complainant points out that the Domain Name appears linked to various commercial websites advertising and selling “Generic” CIALIS brand products, in addition to products which are competitive with Complainant’s product, such as VIAGRA� brand product and LEVITRA� brand product.